The World Health Organization (WHO) has voiced significant ethical concerns regarding a planned hepatitis B birth dose vaccine trial funded by the United States in Guinea-Bissau. Critics, including WHO Director-General and various lawmakers, have labeled the study unethical, raising doubts about its implications and moral justification. The debate continues as stakeholders, including the CDC, are urged to reconsider the ethics behind such vaccine trials, particularly in vulnerable populations.